Jason Adam D'Arcy
Profile
Jason Adam D'Arcy worked as a CFO, Secretary, and Finance Director at Austco Healthcare Ltd.
from 2011 to 2011.
He also worked as a Chief Financial Officer and Secretary at Cellestis Pty Ltd.
and Transpacific Baxter Pty Ltd.
respectively.
Former positions of Jason Adam D'Arcy
| Companies | Position | End |
|---|---|---|
| AUSTCO HEALTHCARE LIMITED | Director of Finance/CFO | 22/10/2018 |
Cellestis Pty Ltd.
 Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Director of Finance/CFO | - |
| BAXTER GROUP LIMITED | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AUSTCO HEALTHCARE LIMITED | Electronic Technology |
| Private companies | 2 |
|---|---|
Transpacific Baxter Pty Ltd.
 Transpacific Baxter Pty Ltd. Environmental ServicesIndustrial Services Transpacific Baxter Pty Ltd. provides waste management services. It offers both inert waste and putrescible waste management and also mines sand from its waste sites, operates a bin hire service and a recycling division. The company was founded in 2002 and is headquartered in Clarinda, Australia. | Industrial Services |
Cellestis Pty Ltd.
Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Health Technology |
- Stock Market
- Insiders
- Jason Adam D'Arcy
